Molecular events in neuroendocrine prostate cancer development
Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer. NEPC arises
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
Molecular events in neuroendocrine prostate cancer development.
Y Wang, X Ci, SYC Choi, F Crea, D Lin - Nature reviews. Urology, 2021 - europepmc.org
Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer. NEPC arises
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
Molecular events in neuroendocrine prostate cancer development
Y Wang, Y Wang, X Ci, SYC Choi, F Crea… - Nature Reviews …, 2021 - oro.open.ac.uk
Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer. NEPC arises
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
[PDF][PDF] Molecular events in neuroendocrine prostate cancer development
Y Wang, Y Wang, X Ci, SYC Choi, F Crea - Nature - researchgate.net
Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer. NEPC arises
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
Molecular events in neuroendocrine prostate cancer development
Y Wang, Y Wang, C Xinpei, F Crea… - Nature Reviews …, 2021 - search.proquest.com
Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer. NEPC arises
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
[HTML][HTML] Molecular events in neuroendocrine prostate cancer development
Y Wang, Y Wang, X Ci, SYC Choi, F Crea… - Nature reviews …, 2021 - ncbi.nlm.nih.gov
Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer. NEPC arises
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
Molecular events in neuroendocrine prostate cancer development
Y Wang, Y Wang, X Ci, SYC Choi… - Nature reviews …, 2021 - pubmed.ncbi.nlm.nih.gov
Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer. NEPC arises
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
Molecular events in neuroendocrine prostate cancer development.
Y Wang, X Ci, SYC Choi, F Crea, D Lin - Nature reviews. Urology, 2021 - europepmc.org
Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer. NEPC arises
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …